Adalimumab trials for Crohn's disease

All Adalimumab trials · All Crohn's disease trials

Phase breakdown

Recruiting trials studying Adalimumab for Crohn's disease

• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
  NCT06045754 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 48 locations
• Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
  NCT06180382 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
  NCT07694674 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Control Crohn Safe Trial
  NCT03917303 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations

Common questions

How many trials study Adalimumab for Crohn's disease?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.